What is the projected market valuation for the Medical Device Testing Services Market in 2035?

The projected market valuation for the Medical Device Testing Services Market in 2035 is 27.01 USD Billion. Read More

What was the market valuation for the Medical Device Testing Services Market in 2024?

The market valuation for the Medical Device Testing Services Market in 2024 was 10.15 USD Billion. Read More

What is the expected CAGR for the Medical Device Testing Services Market from 2025 to 2035?

The expected CAGR for the Medical Device Testing Services Market during the forecast period 2025 - 2035 is 9.3%. Read More

Which segments are included in the Medical Device Testing Services Market?

The segments in the Medical Device Testing Services Market include Biocompatibility Tests, Chemistry Tests, Microbiology & Sterility Tests, Preclinical, and Clinical. Read More

What are the projected values for Biocompatibility Tests by 2035?

The projected value for Biocompatibility Tests is expected to reach 6.5 USD Billion by 2035. Read More

Who are the key players in the Medical Device Testing Services Market?

Key players in the Medical Device Testing Services Market include SGS, Intertek, TÜV SÜD, Bureau Veritas, UL, Eurofins Scientific, Medpace, Pace Analytical, and Charles River Laboratories. Read More

What is the projected value for Clinical testing services by 2035?

The projected value for Clinical testing services is anticipated to be 18.96 USD Billion by 2035. Read More

How much is the Chemistry Tests segment expected to grow by 2035?

The Chemistry Tests segment is expected to grow to 8.0 USD Billion by 2035. Read More

What is the expected growth for Microbiology & Sterility Tests by 2035?

Microbiology & Sterility Tests are projected to reach a value of 12.51 USD Billion by 2035. Read More

What is the projected value for Preclinical testing services by 2035?

The projected value for Preclinical testing services is expected to be 8.05 USD Billion by 2035. Read More

Medical Device Testing Services Market

ID: MRFR/MED/10831-HCR

131 Pages

Vikita Thakur

Last Updated: April 06, 2026

Medical Device Testing Services Market Research Report Information By Services (Biocompatibility Tests, Chemistry Test and Microbiology & Sterility Test), By Phase (Preclinical and Clinical) And By Region (North America, Europe, Asia-Pacific, And Rest Of The World), Forecast Till 2035

Medical Device Testing Services Market Infographic

Summary Table of Contents Segmentation Methodology Download PDF

1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
1. 1.1 EXECUTIVE SUMMARY
  1. 1.1.1 Market Overview
  2. 1.1.2 Key Findings
  3. 1.1.3 Market Segmentation
  4. 1.1.4 Competitive Landscape
  5. 1.1.5 Challenges and Opportunities
  6. 1.1.6 Future Outlook
2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
1. 2.1 MARKET INTRODUCTION
  1. 2.1.1 Definition
  2. 2.1.2 Scope of the study
    1. 2.1.2.1 Research Objective
    2. 2.1.2.2 Assumption
    3. 2.1.2.3 Limitations
2. 2.2 RESEARCH METHODOLOGY
  1. 2.2.1 Overview
  2. 2.2.2 Data Mining
  3. 2.2.3 Secondary Research
  4. 2.2.4 Primary Research
    1. 2.2.4.1 Primary Interviews and Information Gathering Process
    2. 2.2.4.2 Breakdown of Primary Respondents
  5. 2.2.5 Forecasting Model
  6. 2.2.6 Market Size Estimation
    1. 2.2.6.1 Bottom-Up Approach
    2. 2.2.6.2 Top-Down Approach
  7. 2.2.7 Data Triangulation
  8. 2.2.8 Validation
3 SECTION III: QUALITATIVE ANALYSIS
1. 3.1 MARKET DYNAMICS
  1. 3.1.1 Overview
  2. 3.1.2 Drivers
  3. 3.1.3 Restraints
  4. 3.1.4 Opportunities
2. 3.2 MARKET FACTOR ANALYSIS
  1. 3.2.1 Value chain Analysis
  2. 3.2.2 Porter's Five Forces Analysis
    1. 3.2.2.1 Bargaining Power of Suppliers
    2. 3.2.2.2 Bargaining Power of Buyers
    3. 3.2.2.3 Threat of New Entrants
    4. 3.2.2.4 Threat of Substitutes
    5. 3.2.2.5 Intensity of Rivalry
  3. 3.2.3 COVID-19 Impact Analysis
    1. 3.2.3.1 Market Impact Analysis
    2. 3.2.3.2 Regional Impact
    3. 3.2.3.3 Opportunity and Threat Analysis
4 SECTION IV: QUANTITATIVE ANALYSIS
1. 4.1 Healthcare, BY Service (USD Billion)
  1. 4.1.1 Biocompatibility Tests
  2. 4.1.2 Chemistry Tests
  3. 4.1.3 Microbiology & Sterility Tests
2. 4.2 Healthcare, BY Phase (USD Billion)
  1. 4.2.1 Preclinical
  2. 4.2.2 Clinical
3. 4.3 Healthcare, BY Region (USD Billion)
  1. 4.3.1 North America
    1. 4.3.1.1 US
    2. 4.3.1.2 Canada
  2. 4.3.2 Europe
    1. 4.3.2.1 Germany
    2. 4.3.2.2 UK
    3. 4.3.2.3 France
    4. 4.3.2.4 Russia
    5. 4.3.2.5 Italy
    6. 4.3.2.6 Spain
    7. 4.3.2.7 Rest of Europe
  3. 4.3.3 APAC
    1. 4.3.3.1 China
    2. 4.3.3.2 India
    3. 4.3.3.3 Japan
    4. 4.3.3.4 South Korea
    5. 4.3.3.5 Malaysia
    6. 4.3.3.6 Thailand
    7. 4.3.3.7 Indonesia
    8. 4.3.3.8 Rest of APAC
  4. 4.3.4 South America
    1. 4.3.4.1 Brazil
    2. 4.3.4.2 Mexico
    3. 4.3.4.3 Argentina
    4. 4.3.4.4 Rest of South America
  5. 4.3.5 MEA
    1. 4.3.5.1 GCC Countries
    2. 4.3.5.2 South Africa
    3. 4.3.5.3 Rest of MEA
5 SECTION V: COMPETITIVE ANALYSIS
1. 5.1 Competitive Landscape
  1. 5.1.1 Overview
  2. 5.1.2 Competitive Analysis
  3. 5.1.3 Market share Analysis
  4. 5.1.4 Major Growth Strategy in the Healthcare
  5. 5.1.5 Competitive Benchmarking
  6. 5.1.6 Leading Players in Terms of Number of Developments in the Healthcare
  7. 5.1.7 Key developments and growth strategies
    1. 5.1.7.1 New Product Launch/Service Deployment
    2. 5.1.7.2 Merger & Acquisitions
    3. 5.1.7.3 Joint Ventures
  8. 5.1.8 Major Players Financial Matrix
    1. 5.1.8.1 Sales and Operating Income
    2. 5.1.8.2 Major Players R&D Expenditure. 2023
2. 5.2 Company Profiles
  1. 5.2.1 SGS (CH)
    1. 5.2.1.1 Financial Overview
    2. 5.2.1.2 Products Offered
    3. 5.2.1.3 Key Developments
    4. 5.2.1.4 SWOT Analysis
    5. 5.2.1.5 Key Strategies
  2. 5.2.2 Intertek (GB)
    1. 5.2.2.1 Financial Overview
    2. 5.2.2.2 Products Offered
    3. 5.2.2.3 Key Developments
    4. 5.2.2.4 SWOT Analysis
    5. 5.2.2.5 Key Strategies
  3. 5.2.3 TÜV SÜD (DE)
    1. 5.2.3.1 Financial Overview
    2. 5.2.3.2 Products Offered
    3. 5.2.3.3 Key Developments
    4. 5.2.3.4 SWOT Analysis
    5. 5.2.3.5 Key Strategies
  4. 5.2.4 Bureau Veritas (FR)
    1. 5.2.4.1 Financial Overview
    2. 5.2.4.2 Products Offered
    3. 5.2.4.3 Key Developments
    4. 5.2.4.4 SWOT Analysis
    5. 5.2.4.5 Key Strategies
  5. 5.2.5 UL (US)
    1. 5.2.5.1 Financial Overview
    2. 5.2.5.2 Products Offered
    3. 5.2.5.3 Key Developments
    4. 5.2.5.4 SWOT Analysis
    5. 5.2.5.5 Key Strategies
  6. 5.2.6 Eurofins Scientific (LU)
    1. 5.2.6.1 Financial Overview
    2. 5.2.6.2 Products Offered
    3. 5.2.6.3 Key Developments
    4. 5.2.6.4 SWOT Analysis
    5. 5.2.6.5 Key Strategies
  7. 5.2.7 Medpace (US)
    1. 5.2.7.1 Financial Overview
    2. 5.2.7.2 Products Offered
    3. 5.2.7.3 Key Developments
    4. 5.2.7.4 SWOT Analysis
    5. 5.2.7.5 Key Strategies
  8. 5.2.8 Pace Analytical (US)
    1. 5.2.8.1 Financial Overview
    2. 5.2.8.2 Products Offered
    3. 5.2.8.3 Key Developments
    4. 5.2.8.4 SWOT Analysis
    5. 5.2.8.5 Key Strategies
  9. 5.2.9 Charles River Laboratories (US)
    1. 5.2.9.1 Financial Overview
    2. 5.2.9.2 Products Offered
    3. 5.2.9.3 Key Developments
    4. 5.2.9.4 SWOT Analysis
    5. 5.2.9.5 Key Strategies
3. 5.3 Appendix
  1. 5.3.1 References
  2. 5.3.2 Related Reports
6 LIST OF FIGURES
1. 6.1 MARKET SYNOPSIS
2. 6.2 NORTH AMERICA MARKET ANALYSIS
3. 6.3 US MARKET ANALYSIS BY SERVICE
4. 6.4 US MARKET ANALYSIS BY PHASE
5. 6.5 CANADA MARKET ANALYSIS BY SERVICE
6. 6.6 CANADA MARKET ANALYSIS BY PHASE
7. 6.7 EUROPE MARKET ANALYSIS
8. 6.8 GERMANY MARKET ANALYSIS BY SERVICE
9. 6.9 GERMANY MARKET ANALYSIS BY PHASE
10. 6.10 UK MARKET ANALYSIS BY SERVICE
11. 6.11 UK MARKET ANALYSIS BY PHASE
12. 6.12 FRANCE MARKET ANALYSIS BY SERVICE
13. 6.13 FRANCE MARKET ANALYSIS BY PHASE
14. 6.14 RUSSIA MARKET ANALYSIS BY SERVICE
15. 6.15 RUSSIA MARKET ANALYSIS BY PHASE
16. 6.16 ITALY MARKET ANALYSIS BY SERVICE
17. 6.17 ITALY MARKET ANALYSIS BY PHASE
18. 6.18 SPAIN MARKET ANALYSIS BY SERVICE
19. 6.19 SPAIN MARKET ANALYSIS BY PHASE
20. 6.20 REST OF EUROPE MARKET ANALYSIS BY SERVICE
21. 6.21 REST OF EUROPE MARKET ANALYSIS BY PHASE
22. 6.22 APAC MARKET ANALYSIS
23. 6.23 CHINA MARKET ANALYSIS BY SERVICE
24. 6.24 CHINA MARKET ANALYSIS BY PHASE
25. 6.25 INDIA MARKET ANALYSIS BY SERVICE
26. 6.26 INDIA MARKET ANALYSIS BY PHASE
27. 6.27 JAPAN MARKET ANALYSIS BY SERVICE
28. 6.28 JAPAN MARKET ANALYSIS BY PHASE
29. 6.29 SOUTH KOREA MARKET ANALYSIS BY SERVICE
30. 6.30 SOUTH KOREA MARKET ANALYSIS BY PHASE
31. 6.31 MALAYSIA MARKET ANALYSIS BY SERVICE
32. 6.32 MALAYSIA MARKET ANALYSIS BY PHASE
33. 6.33 THAILAND MARKET ANALYSIS BY SERVICE
34. 6.34 THAILAND MARKET ANALYSIS BY PHASE
35. 6.35 INDONESIA MARKET ANALYSIS BY SERVICE
36. 6.36 INDONESIA MARKET ANALYSIS BY PHASE
37. 6.37 REST OF APAC MARKET ANALYSIS BY SERVICE
38. 6.38 REST OF APAC MARKET ANALYSIS BY PHASE
39. 6.39 SOUTH AMERICA MARKET ANALYSIS
40. 6.40 BRAZIL MARKET ANALYSIS BY SERVICE
41. 6.41 BRAZIL MARKET ANALYSIS BY PHASE
42. 6.42 MEXICO MARKET ANALYSIS BY SERVICE
43. 6.43 MEXICO MARKET ANALYSIS BY PHASE
44. 6.44 ARGENTINA MARKET ANALYSIS BY SERVICE
45. 6.45 ARGENTINA MARKET ANALYSIS BY PHASE
46. 6.46 REST OF SOUTH AMERICA MARKET ANALYSIS BY SERVICE
47. 6.47 REST OF SOUTH AMERICA MARKET ANALYSIS BY PHASE
48. 6.48 MEA MARKET ANALYSIS
49. 6.49 GCC COUNTRIES MARKET ANALYSIS BY SERVICE
50. 6.50 GCC COUNTRIES MARKET ANALYSIS BY PHASE
51. 6.51 SOUTH AFRICA MARKET ANALYSIS BY SERVICE
52. 6.52 SOUTH AFRICA MARKET ANALYSIS BY PHASE
53. 6.53 REST OF MEA MARKET ANALYSIS BY SERVICE
54. 6.54 REST OF MEA MARKET ANALYSIS BY PHASE
55. 6.55 KEY BUYING CRITERIA OF HEALTHCARE
56. 6.56 RESEARCH PROCESS OF MRFR
57. 6.57 DRO ANALYSIS OF HEALTHCARE
58. 6.58 DRIVERS IMPACT ANALYSIS: HEALTHCARE
59. 6.59 RESTRAINTS IMPACT ANALYSIS: HEALTHCARE
60. 6.60 SUPPLY / VALUE CHAIN: HEALTHCARE
61. 6.61 HEALTHCARE, BY SERVICE, 2024 (% SHARE)
62. 6.62 HEALTHCARE, BY SERVICE, 2024 TO 2035 (USD Billion)
63. 6.63 HEALTHCARE, BY PHASE, 2024 (% SHARE)
64. 6.64 HEALTHCARE, BY PHASE, 2024 TO 2035 (USD Billion)
65. 6.65 BENCHMARKING OF MAJOR COMPETITORS
7 LIST OF TABLES
1. 7.1 LIST OF ASSUMPTIONS
7.1.1
1. 7.2 North America MARKET SIZE ESTIMATES; FORECAST
  1. 7.2.1 BY SERVICE, 2025-2035 (USD Billion)
  2. 7.2.2 BY PHASE, 2025-2035 (USD Billion)
2. 7.3 US MARKET SIZE ESTIMATES; FORECAST
  1. 7.3.1 BY SERVICE, 2025-2035 (USD Billion)
  2. 7.3.2 BY PHASE, 2025-2035 (USD Billion)
3. 7.4 Canada MARKET SIZE ESTIMATES; FORECAST
  1. 7.4.1 BY SERVICE, 2025-2035 (USD Billion)
  2. 7.4.2 BY PHASE, 2025-2035 (USD Billion)
4. 7.5 Europe MARKET SIZE ESTIMATES; FORECAST
  1. 7.5.1 BY SERVICE, 2025-2035 (USD Billion)
  2. 7.5.2 BY PHASE, 2025-2035 (USD Billion)
5. 7.6 Germany MARKET SIZE ESTIMATES; FORECAST
  1. 7.6.1 BY SERVICE, 2025-2035 (USD Billion)
  2. 7.6.2 BY PHASE, 2025-2035 (USD Billion)
6. 7.7 UK MARKET SIZE ESTIMATES; FORECAST
  1. 7.7.1 BY SERVICE, 2025-2035 (USD Billion)
  2. 7.7.2 BY PHASE, 2025-2035 (USD Billion)
7. 7.8 France MARKET SIZE ESTIMATES; FORECAST
  1. 7.8.1 BY SERVICE, 2025-2035 (USD Billion)
  2. 7.8.2 BY PHASE, 2025-2035 (USD Billion)
8. 7.9 Russia MARKET SIZE ESTIMATES; FORECAST
  1. 7.9.1 BY SERVICE, 2025-2035 (USD Billion)
  2. 7.9.2 BY PHASE, 2025-2035 (USD Billion)
9. 7.10 Italy MARKET SIZE ESTIMATES; FORECAST
  1. 7.10.1 BY SERVICE, 2025-2035 (USD Billion)
  2. 7.10.2 BY PHASE, 2025-2035 (USD Billion)
10. 7.11 Spain MARKET SIZE ESTIMATES; FORECAST
  1. 7.11.1 BY SERVICE, 2025-2035 (USD Billion)
  2. 7.11.2 BY PHASE, 2025-2035 (USD Billion)
11. 7.12 Rest of Europe MARKET SIZE ESTIMATES; FORECAST
  1. 7.12.1 BY SERVICE, 2025-2035 (USD Billion)
  2. 7.12.2 BY PHASE, 2025-2035 (USD Billion)
12. 7.13 APAC MARKET SIZE ESTIMATES; FORECAST
  1. 7.13.1 BY SERVICE, 2025-2035 (USD Billion)
  2. 7.13.2 BY PHASE, 2025-2035 (USD Billion)
13. 7.14 China MARKET SIZE ESTIMATES; FORECAST
  1. 7.14.1 BY SERVICE, 2025-2035 (USD Billion)
  2. 7.14.2 BY PHASE, 2025-2035 (USD Billion)
14. 7.15 India MARKET SIZE ESTIMATES; FORECAST
  1. 7.15.1 BY SERVICE, 2025-2035 (USD Billion)
  2. 7.15.2 BY PHASE, 2025-2035 (USD Billion)
15. 7.16 Japan MARKET SIZE ESTIMATES; FORECAST
  1. 7.16.1 BY SERVICE, 2025-2035 (USD Billion)
  2. 7.16.2 BY PHASE, 2025-2035 (USD Billion)
16. 7.17 South Korea MARKET SIZE ESTIMATES; FORECAST
  1. 7.17.1 BY SERVICE, 2025-2035 (USD Billion)
  2. 7.17.2 BY PHASE, 2025-2035 (USD Billion)
17. 7.18 Malaysia MARKET SIZE ESTIMATES; FORECAST
  1. 7.18.1 BY SERVICE, 2025-2035 (USD Billion)
  2. 7.18.2 BY PHASE, 2025-2035 (USD Billion)
18. 7.19 Thailand MARKET SIZE ESTIMATES; FORECAST
  1. 7.19.1 BY SERVICE, 2025-2035 (USD Billion)
  2. 7.19.2 BY PHASE, 2025-2035 (USD Billion)
19. 7.20 Indonesia MARKET SIZE ESTIMATES; FORECAST
  1. 7.20.1 BY SERVICE, 2025-2035 (USD Billion)
  2. 7.20.2 BY PHASE, 2025-2035 (USD Billion)
20. 7.21 Rest of APAC MARKET SIZE ESTIMATES; FORECAST
  1. 7.21.1 BY SERVICE, 2025-2035 (USD Billion)
  2. 7.21.2 BY PHASE, 2025-2035 (USD Billion)
21. 7.22 South America MARKET SIZE ESTIMATES; FORECAST
  1. 7.22.1 BY SERVICE, 2025-2035 (USD Billion)
  2. 7.22.2 BY PHASE, 2025-2035 (USD Billion)
22. 7.23 Brazil MARKET SIZE ESTIMATES; FORECAST
  1. 7.23.1 BY SERVICE, 2025-2035 (USD Billion)
  2. 7.23.2 BY PHASE, 2025-2035 (USD Billion)
23. 7.24 Mexico MARKET SIZE ESTIMATES; FORECAST
  1. 7.24.1 BY SERVICE, 2025-2035 (USD Billion)
  2. 7.24.2 BY PHASE, 2025-2035 (USD Billion)
24. 7.25 Argentina MARKET SIZE ESTIMATES; FORECAST
  1. 7.25.1 BY SERVICE, 2025-2035 (USD Billion)
  2. 7.25.2 BY PHASE, 2025-2035 (USD Billion)
25. 7.26 Rest of South America MARKET SIZE ESTIMATES; FORECAST
  1. 7.26.1 BY SERVICE, 2025-2035 (USD Billion)
  2. 7.26.2 BY PHASE, 2025-2035 (USD Billion)
26. 7.27 MEA MARKET SIZE ESTIMATES; FORECAST
  1. 7.27.1 BY SERVICE, 2025-2035 (USD Billion)
  2. 7.27.2 BY PHASE, 2025-2035 (USD Billion)
27. 7.28 GCC Countries MARKET SIZE ESTIMATES; FORECAST
  1. 7.28.1 BY SERVICE, 2025-2035 (USD Billion)
  2. 7.28.2 BY PHASE, 2025-2035 (USD Billion)
28. 7.29 South Africa MARKET SIZE ESTIMATES; FORECAST
  1. 7.29.1 BY SERVICE, 2025-2035 (USD Billion)
  2. 7.29.2 BY PHASE, 2025-2035 (USD Billion)
29. 7.30 Rest of MEA MARKET SIZE ESTIMATES; FORECAST
  1. 7.30.1 BY SERVICE, 2025-2035 (USD Billion)
  2. 7.30.2 BY PHASE, 2025-2035 (USD Billion)
30. 7.31 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
7.31.1
1. 7.32 ACQUISITION/PARTNERSHIP
7.32.1

Certified Researchers

Customize Report

Healthcare Market Segmentation

Healthcare By Service (USD Billion, 2025-2035)

Biocompatibility Tests
Chemistry Tests
Microbiology & Sterility Tests

Healthcare By Phase (USD Billion, 2025-2035)

Preclinical
Clinical

Customer Stories

“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”

Noah Malgeri Co-Founder

“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”

Joseph Aguayo Sales Operations & Pricing Manager

“Thanks for sending the report it gives us a good global view of the Betaïne market.”

Peter Groot koerkamp Account and Business Manager

“Thank you, this will be very helpful for OQS.”

La Terria Dodd Program Support Specialist

“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”

Younghwan Choi Senior Retail Manager

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Mark Irwin Management Consultant

“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”

Rob Kooiker Group Product Manager HVAC & Fire Protection GMA

“We got the report in time, we really thank you for your support in this process. I also thank to all of your team as they did a great job.”

Akif Moroglu Strategy & Business Development Director

Case Study

Aerospace & Defense

Future of Dismounted Soldier Systems Market Trends & Adoption Roadmap 2019–2035

Features	License Type
Features	Single User	Multiuser License	Enterprise User
Price	$4,950	$5,950	$7,250
Maximum User Access Limit	1 User	Upto 10 Users	Unrestricted Access Throughout the Organization
Free Customization	✓	✓	✓
Direct Access to Analyst	✓	✓	✓
Deliverable Format	✓	✓	✓
Platform Access	✗	✗	✓
Discount on Next Purchase	10%	15%	15%
Printable Versions	✗	✗	✓